You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API oxycodone hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing oxycodone hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Teva Pharmaceuticals USA Inc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride 0093-5731 BUTYLATED HYDROXYTOLUENE
Teva Pharmaceuticals USA Inc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride 0093-5731 HYDROXYPROPYL CELLULOSE
Teva Pharmaceuticals USA Inc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride 0093-5731 HYPROMELLOSE
Teva Pharmaceuticals USA Inc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride 0093-5731 MAGNESIUM STEARATE
Teva Pharmaceuticals USA Inc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride 0093-5731 POLYETHYLENE GLYCOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing oxycodone hydrochloride

Company Ingredient NDC Excipient
Hikma Pharmceuticals USA Inc oxycodone hydrochloride 0054-0390 ANHYDROUS CITRIC ACID
Hikma Pharmceuticals USA Inc oxycodone hydrochloride 0054-0390 EDETATE DISODIUM
Hikma Pharmceuticals USA Inc oxycodone hydrochloride 0054-0390 FD&C RED NO. 40
Hikma Pharmceuticals USA Inc oxycodone hydrochloride 0054-0390 SODIUM BENZOATE
Hikma Pharmceuticals USA Inc oxycodone hydrochloride 0054-0390 SORBITOL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for oxycodone hydrochloride

Excipient focus: ACESULFAME POTASSIUM

Excipient focus: ALCOHOL

Excipient focus: ALGINIC ACID

Excipient focus: ALUMINUM HYDROXIDE

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMINO METHACRYLATE COPOLYMER

Excipient focus: AMMONIA

Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE B

oxycodone hydrochloride drug variants not containing AMMONIO METHACRYLATE COPOLYMER TYPE B

Company Ingredient NDC
Hikma Pharmceuticals USA Inc oxycodone hydrochloride 0054-0390
Teva Pharmaceuticals USA Inc oxycodone hydrochloride 0093-5731
Amneal Pharmaceuticals of New York LLC oxycodone hydrochloride 0115-1556
Pharmaceutical Associates Inc oxycodone hydrochloride 0121-0826
PAI Holdings LLC oxycodone hydrochloride 0121-0827
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BERRY

Excipient focus: BUTYL ALCOHOL

Excipient focus: BUTYLATED HYDROXYTOLUENE

Excipient focus: CALCIUM STEARATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

oxycodone hydrochloride drug variants containing CROSCARMELLOSE SODIUM

Company Ingredient NDC
Par Pharmaceutical oxycodone hydrochloride and acetaminophen 0603-4978
Par Pharmaceutical oxycodone hydrochloride and acetaminophen 0603-4979
Par Pharmaceutical oxycodone hydrochloride and acetaminophen 0603-4998
Major Pharmaceuticals oxycodone hydrochloride and acetaminophen 0904-6437
Major Pharmaceuticals oxycodone hydrochloride and acetaminophen 0904-6438
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 27

Excipient focus: D&C RED NO. 30

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DIBUTYL SEBACATE

Excipient focus: DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

oxycodone hydrochloride drug variants not containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

Company Ingredient NDC
Hikma Pharmceuticals USA Inc oxycodone hydrochloride 0054-0390
Teva Pharmaceuticals USA Inc oxycodone hydrochloride 0093-5731
Amneal Pharmaceuticals of New York LLC oxycodone hydrochloride 0115-1556
Pharmaceutical Associates Inc oxycodone hydrochloride 0121-0826
PAI Holdings LLC oxycodone hydrochloride 0121-0827
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: EDETATE DISODIUM

Excipient focus: ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION

oxycodone hydrochloride drug variants not containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION

Company Ingredient NDC
Hikma Pharmceuticals USA Inc oxycodone hydrochloride 0054-0390
Teva Pharmaceuticals USA Inc oxycodone hydrochloride 0093-5731
Amneal Pharmaceuticals of New York LLC oxycodone hydrochloride 0115-1556
Pharmaceutical Associates Inc oxycodone hydrochloride 0121-0826
PAI Holdings LLC oxycodone hydrochloride 0121-0827
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: ETHYLCELLULOSE

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: FRUCTOSE

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTITOL

Excipient focus: MANNITOL

Excipient focus: METHYL ALCOHOL

Excipient focus: POLOXAMER 188

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POTASSIUM CITRATE

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POTASSIUM SORBATE

Excipient focus: POVIDONE

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: RASPBERRY

Excipient focus: SACCHARIN

Excipient focus: SACCHARIN SODIUM

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM ALGINATE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM GLUCONATE

Excipient focus: SODIUM GLYCOLATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC, DIHYDRATE

oxycodone hydrochloride drug variants not containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE

Company Ingredient NDC
Hikma Pharmceuticals USA Inc oxycodone hydrochloride 0054-0390
Teva Pharmaceuticals USA Inc oxycodone hydrochloride 0093-5731
Amneal Pharmaceuticals of New York LLC oxycodone hydrochloride 0115-1556
Pharmaceutical Associates Inc oxycodone hydrochloride 0121-0826
PAI Holdings LLC oxycodone hydrochloride 0121-0827
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

oxycodone hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
Hikma Pharmceuticals USA Inc oxycodone hydrochloride 0054-0390
Teva Pharmaceuticals USA Inc oxycodone hydrochloride 0093-5731
Amneal Pharmaceuticals of New York LLC oxycodone hydrochloride 0115-1556
Pharmaceutical Associates Inc oxycodone hydrochloride 0121-0826
PAI Holdings LLC oxycodone hydrochloride 0121-0827
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SORBIC ACID

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: STEARIC ACID

Excipient focus: STEARYL ALCOHOL

Excipient focus: SUCRALOSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group